Moderna's mRNA Vaccine Cuts Melanoma Relapse in 1,137-Patient Phase 3 Trial
Left37%
Center53%
Far Right11%
Moderna's Intismeran mRNA Vaccine Succeeds in Late-Stage Melanoma TrialThe New York Times14h ago Moderna Stock Surges 177% on Successful Cancer Vaccine Trial with MerckModerna Stock Surges 120% on Positive Cancer Vaccine Trial ResultsModerna, Merck Stocks Surge on Positive Personalized Cancer Vaccine Trial ResultsModerna, Merck's Melanoma Vaccine Succeeds in Late-Stage Trial, Shares SurgeMerck, Moderna say melanoma vaccine meets goals in large trial | WTAQ News Talk | 97.5 FM · 1360 AM | Green Bay, WIInvestor's Business Daily1d ago Moderna Stock Doubles on Cancer Vaccine News; Major Indexes End Losing StreakModerna shares soar 60% on melanoma vaccine trial successModerna mRNA Cancer Treatment Meets Melanoma Study Goal, Shares SoarModerna Stock Surges 177% on Cancer Vaccine Trial Success, Burning Short SellersModerna Stock Soars 90% on Positive Late-Stage Cancer Vaccine Trial ResultsModerna, Merck Cancer Vaccine Shows Promise in Late-Stage Trial; Moderna Stock Soars 100%Moderna, Merck, Target Stocks Hit 52-Week Highs on Cancer Trial Results and Strong Q2Moderna Shares Soar 177% on Phase 3 Melanoma Vaccine Success with MerckModerna Stock Skyrockets 177% on Positive Phase 3 Melanoma Data with MerckGreater Baton Rouge Business Report1d ago Moderna, Keytruda Personalized Cancer Vaccine Shows Success in Phase Three Melanoma TrialVaccine stocks jump on Moderna's melanoma vaccine trial results By Investing.comInvesting.com Canada1d ago Vaccine stocks jump on Moderna's melanoma vaccine trial results By Investing.comPREMARKET MOVES | Moderna, Merck Surge on Positive Late-Stage Cancer Vaccine Trial Results | Binance News on Binance SquareMerck, Moderna say melanoma skin cancer vaccine meets goals in large trial - NewsBreakKTVU FOX 2 San Francisco1d ago Moderna's mRNA Cancer Vaccine Cuts Melanoma Risk, Shares Surge 160%